A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression.
Publication
, Preprint
Plebanek, MP; Xue, Y; Nguyen, Y-V; DeVito, NC; Wang, X; Holtzhausen, A; Beasley, GM; Yarla, N; Thievanthiran, B; Hanks, BA
April 28, 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Plebanek, M. P., Xue, Y., Nguyen, Y.-V., DeVito, N. C., Wang, X., Holtzhausen, A., … Hanks, B. A. (2023). A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression. https://doi.org/10.1101/2023.04.26.538456
Plebanek, Michael P., Yue Xue, Y-Van Nguyen, Nicholas C. DeVito, Xueying Wang, Alisha Holtzhausen, Georgia M. Beasley, Nagendra Yarla, Bala Thievanthiran, and Brent A. Hanks. “A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression.,” April 28, 2023. https://doi.org/10.1101/2023.04.26.538456.
Plebanek MP, Xue Y, Nguyen Y-V, DeVito NC, Wang X, Holtzhausen A, et al. A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression. 2023.
Plebanek, Michael P., et al. A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression. 28 Apr. 2023. Pubmed, doi:10.1101/2023.04.26.538456.
Plebanek MP, Xue Y, Nguyen Y-V, DeVito NC, Wang X, Holtzhausen A, Beasley GM, Yarla N, Thievanthiran B, Hanks BA. A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression. 2023.